JP2008001722A5 - - Google Patents

Download PDF

Info

Publication number
JP2008001722A5
JP2008001722A5 JP2007238577A JP2007238577A JP2008001722A5 JP 2008001722 A5 JP2008001722 A5 JP 2008001722A5 JP 2007238577 A JP2007238577 A JP 2007238577A JP 2007238577 A JP2007238577 A JP 2007238577A JP 2008001722 A5 JP2008001722 A5 JP 2008001722A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
composition
glutathione
agent according
extender
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007238577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008001722A (ja
Filing date
Publication date
Priority claimed from RU95120403/14A external-priority patent/RU2089179C1/ru
Application filed filed Critical
Publication of JP2008001722A publication Critical patent/JP2008001722A/ja
Publication of JP2008001722A5 publication Critical patent/JP2008001722A5/ja
Pending legal-status Critical Current

Links

JP2007238577A 1995-12-14 2007-09-13 サイトカインおよび造血因子の内因性産生増強因子とその利用方法 Pending JP2008001722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU95120403/14A RU2089179C1 (ru) 1995-12-14 1995-12-14 Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
PCT/RU1996/000226 WO1997021443A1 (en) 1995-12-14 1996-08-08 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP09521965A Division JP2000515111A (ja) 1995-12-14 1996-12-10 サイトカインおよび造血因子の内因性産生増強因子とその利用方法

Publications (2)

Publication Number Publication Date
JP2008001722A JP2008001722A (ja) 2008-01-10
JP2008001722A5 true JP2008001722A5 (cg-RX-API-DMAC7.html) 2009-01-29

Family

ID=26653679

Family Applications (2)

Application Number Title Priority Date Filing Date
JP09521965A Withdrawn JP2000515111A (ja) 1995-12-14 1996-12-10 サイトカインおよび造血因子の内因性産生増強因子とその利用方法
JP2007238577A Pending JP2008001722A (ja) 1995-12-14 2007-09-13 サイトカインおよび造血因子の内因性産生増強因子とその利用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP09521965A Withdrawn JP2000515111A (ja) 1995-12-14 1996-12-10 サイトカインおよび造血因子の内因性産生増強因子とその利用方法

Country Status (8)

Country Link
EP (1) EP0869809B1 (cg-RX-API-DMAC7.html)
JP (2) JP2000515111A (cg-RX-API-DMAC7.html)
AT (1) ATE214936T1 (cg-RX-API-DMAC7.html)
AU (1) AU1113097A (cg-RX-API-DMAC7.html)
CA (1) CA2239874A1 (cg-RX-API-DMAC7.html)
DE (1) DE69620233T2 (cg-RX-API-DMAC7.html)
ES (1) ES2174124T3 (cg-RX-API-DMAC7.html)
WO (1) WO1997021444A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746946B2 (en) * 1997-03-21 2002-05-09 Shiseido Company Ltd. Immunopotentiators
IL123887A0 (en) * 1997-04-02 1998-10-30 Sankyo Co Dithiolan derivatives their use and pharmaceutical compositions containing the same
JP2002509715A (ja) * 1998-03-30 2002-04-02 イ・デ・エム・イミュノ−デジネ・モレキュル 刺激された単球に由来する細胞、その調製及び用途
JP2000169371A (ja) * 1998-10-02 2000-06-20 Sankyo Co Ltd ジチオラン誘導体を含有する医薬
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
US6312734B1 (en) * 1998-11-23 2001-11-06 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких
US7173013B2 (en) 2001-06-08 2007-02-06 Sciclone Pharmaceuticals, Inc. Treatment of tuberculosis using immunomodulator compounds
EP1596756A4 (en) * 2003-01-23 2009-11-11 Supernus Pharmaceuticals Inc MEANS TO INCREASE ABSORPTION
RU2482868C1 (ru) * 2011-12-30 2013-05-27 Общество С Ограниченной Ответственностью "Ива Фарм" Средство для лечения диабета, фармацевтическая композиция и способ лечения заболеваний
ES2659199T3 (es) * 2012-09-28 2018-03-14 Kyowa Hakko Bio Co., Ltd. Agente para aumentar la inmunidad que contiene glutatión
RU2545900C2 (ru) * 2013-05-07 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ диагностики апоптоза лимфоцитов
RU2540500C2 (ru) * 2013-05-07 2015-02-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ прогнозирования ранней стадии апоптоза
RU2659161C1 (ru) 2017-11-17 2018-06-28 Общество С Ограниченной Ответственностью "Ива Фарм" Фармацевтическая композиция, включающая дисульфид глутатиона и глутатион дисульфид s-оксид
CN114617899B (zh) * 2022-04-14 2023-10-20 苏州大学附属儿童医院 S-腺苷甲硫氨酸在制备治疗脓毒血症相关性脑病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277619A (ja) * 1985-06-04 1986-12-08 Otsuka Pharmaceut Factory Inc 肝疾患治療剤
JP2921124B2 (ja) * 1990-12-28 1999-07-19 千寿製薬株式会社 酸化型グルタチオンアルキルエステル
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
US5618823A (en) * 1992-06-24 1997-04-08 Boehringer Mannheim Italia S.P.A. Glutathione as chemoprotective agent
GB9303854D0 (en) * 1993-02-25 1993-04-14 Holt John A G Method for enhancing t-cell count

Similar Documents

Publication Publication Date Title
CA2531862A1 (en) Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CA2501651A1 (en) Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CA2504730A1 (en) Cephem compounds
CA2656858A1 (en) Positively charged water-soluble prodrugs of acetylsalicylic acid
JP2007518805A5 (cg-RX-API-DMAC7.html)
CA2464758A1 (en) Combination therapy comprising zd6474 and a taxane
CN1416431A (zh) 核苷化合物及其应用
JP2008545793A5 (cg-RX-API-DMAC7.html)
JP2019131579A5 (cg-RX-API-DMAC7.html)
AU2016250616B2 (en) Co-crystal composition and its pharmaceutical use
Berenson et al. Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy
EP1460077A1 (en) Novel pyrazolopyrimidones and their use as PDE inhibitors
PT1613315E (pt) Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias
WO2001012169A3 (en) Method of cancer treatment
JP2004510778A (ja) 抗腫瘍剤としての白金錯体
WO1999018099B1 (en) Aryl thiophene derivatives as pde iv inhibitors
JP2023109829A5 (cg-RX-API-DMAC7.html)
JP4201346B2 (ja) 白金およびテルルまたはセレン化合物の併用により腫瘍の発育を減少させる方法および組成物
JP2006523664A5 (cg-RX-API-DMAC7.html)
CA2531620A1 (en) Cancer combination therapy comprising azd2171 and zd1839
EP1303307B1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
WO2009067225A4 (en) Boceprevir derivatives for the treatment of hcv infections
EP0281463A2 (en) Platinum complex, process for its preparation and pharmaceutical composition including such a complex
JPH08501069A (ja) 強心剤と一酸化窒素合成抑制剤の併用による病的低血圧の治療
KR20250026146A (ko) 붕소 화합물의 전구약물 및 박테리아 감염 치료에 있어서의 이의 용도